GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Rafael Holdings Inc (NYSE:RFL) » Definitions » Sale Of Investment

Rafael Holdings (Rafael Holdings) Sale Of Investment : $216.68 Mil (TTM As of Jan. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Rafael Holdings Sale Of Investment?

Rafael Holdings's sale of investment for the three months ended in Jan. 2024 was $55.13 Mil. It means Rafael Holdings gained $55.13 Mil from selling investments. Rafael Holdings's sale of investment for the trailing twelve months (TTM) ended in Jan. 2024 was $216.68 Mil.

Compared with last quarter ($47.73 Mil in Oct. 2023 ), Rafael Holdings gained more money from selling investments in Jan. 2024 ($55.13 Mil).


Rafael Holdings Sale Of Investment Historical Data

The historical data trend for Rafael Holdings's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rafael Holdings Sale Of Investment Chart

Rafael Holdings Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Sale Of Investment
Get a 7-Day Free Trial 25.03 - - 28.50 185.20

Rafael Holdings Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.46 65.59 48.23 47.73 55.13

Rafael Holdings Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $216.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rafael Holdings Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Rafael Holdings's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Rafael Holdings (Rafael Holdings) Business Description

Traded in Other Exchanges
N/A
Address
520 Broad Street, Newark, NJ, USA, 07102
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.
Executives
I9 Plus, Llc 10 percent owner 153 BOOTH AVE, ENGLEWOOD NJ 07631
Howard S Jonas director
Mary Margaret Huizinga officer: Chief Devel. & Medical Officer C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
Ashok D Marin officer: Chief Legal Officer C/O LIPOSCIENCE, INC., 2500 SUMNER BOULEVARD, RALEIGH NC 27616
Patrick Fabbio officer: Chief Financial Officer 2 PITNEY COURT, BASKING RIDGE NJ 07920
Mark Anthony Mccamish director C/O FORTY SEVEN, INC., 1490 O'BRIEN DRIVE, SUITE A, MENLO PARK CA 94025
Shannon Thyme Klinger director 200 TECHNOLOGY SQUARE, SUITE 300, CAMBRIDGE MA 02139
Ameet Mallik officer: CHIEF EXECUTIVE OFFICER C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
William Conkling officer: Chief Commercial Officer C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
Rachel Jonas director C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
Boris C Pasche director C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
Michael J Weiss director C/O NET2PHONE INC, 520 BROAD ST, NEWARK NJ 07102
Stephen M Greenberg director C/O NET2PHONE INC, 520 BROAD ST, NEWARK NJ 07102
David Polinsky officer: Chief Financial Officer 90 BOOTH AVENUE, ENGLEWOOD NJ 07631
Menachem Ash director, officer: President C/O IDT CORPORATION, 520 BROAD STREET, NEWARK NJ 07102

Rafael Holdings (Rafael Holdings) Headlines

From GuruFocus